Mass tort builds over Mirena IUD injuries 
By:
Sylvia Hsieh
Published: April 5, 2013
Tags: Bayer Healthcare, contraceptives, mass tort, Mirena IUD, product liability
A mass tort is taking shape over the Mirena IUD, a device that many women claim migrates after insertion and becomes embedded in the uterus or punctures organs, requiring surgical removal and sometimes causing infection and other injuries.
O’Quinn firm faces suit over expenses
Published: January 7, 2013
Tags: breach of contract, breach of fiduciary duty, deceptive trade practices, ethics, fraud, legal ethics, mass tort, negligence, referral fees, settlements, silicosis litigation
According to a lawsuit filed by former clients, the Texas-based O’Quinn law firm mishandled their silicosis litigation settlement funds.
Pelvic mesh defect litigation on the increase
By:
Sylvia Hsieh
Published: November 4, 2011
Tags: CR Bard, mass tort, pelvic mesh, vaginal mesh
Product liability lawsuits alleging that vaginal mesh devices implanted in women are defective and that manufacturers failed to warn about their dangers are shaping up into a widespread mass tort.
Suits start stacking up across the country in Actos mass tort
By:
Sylvia Hsieh
Published: August 31, 2011
Tags: Actos, cancer, causation, Eli Lilly and Company, mass tort, product liability, Takeda North America
Litigation over the drug Actos is gaining momentum as a mass tort.
Attorneys investigating contraceptive-gallbladder link
By:
Sylvia Hsieh
Published: January 19, 2010
Tags: drug litigation, mass tort, Yasmin, Yaz
In addition to blood clotting injuries related to the contraceptive Yaz/Yasmin, plaintiffs’ attorneys are investigating claims that the fourth generation birth control pills also cause gallbladder problems.
Newest type of birth control pills gives rise to mass tort
By:
Sylvia Hsieh
Published: July 17, 2009
Tags: drug litigation, mass tort
The newest form of combined oral contraceptives has given birth to a mass tort.
Several lawsuits have been filed in federal court against Bayer Corp. over Yaz/Yasmin birth control pills, alleging that a new ingredient in this “fourth generation” contraceptive presents dangerous risks that the company failed to warn about.
